Web Flow - Login to access your portal

PCI and Serialization Partners Host London Serialization Forum

PCI Pharma Services, in collaboration with Antares, Crest Solutions and Multi-Packaging Solutions (MPS), will host a free educational Serialization Forum on January 24 at Heathrow Windsor Marriott Hotel, London, UK.

With drug counterfeiting on the rise globally and regulatory deadlines fast approaching, the pharmaceutical supply chain will soon be at critical point to ensure patient safety. From drug manufacturers to distributors, all supply chain partners will need to make crucial decisions to upgrade their production lines in compliance with DSCSA, FMD, and emerging market traceability deadlines.

PCI’s latest Serialization seminar will bring together some of the brightest minds in the industry to share their experience and best practices for executing an effective Serialization strategy. Christoph Krähenbühl, Senior Director at leading European Serialization consulting firm 3C Integrity will be opening the session with his presentation ‘State of Readiness’, giving his insights on preparing for the industry’s pending global Serialization requirements. 3C Integrity recently joined forces with leading US consulting firm Excellis Health.

Ian Parsonage, Senior Director of Global Serialization at PCI will share his expertise on lessons learned, as well as best practices in Serialization. PCI features extensive Serialization experience, actively providing Serialized product to both domestic and emerging global markets across an extensive multinational supply network. Parsonage’s presentation will be complemented by Elliot Abreu, Senior Vice President at Xyntek Inc. and Frank Madden, Founder and CEO of Crest Solutions, who will provide their advice for pharmaceutical firms on succeeding in Serialization strategy and implementation. Xyntek is the US partner integrator for Antares Vision Serialization technologies and Crest Solutions operates as partner integrator for the European market. Both firms feature extensive history with successful installations at leading pharmaceutical firms and CMO’s.

Attendees will also hear from key sector leaders at leading pharmaceutical companies during a pharmaceutical industry roundtable session, where practical experiences and best practices will be discussed. Leading full service print and packaging supplier MPS will provide a demonstration and forum for leading anti-counterfeiting material technologies that can complement Serialization strategies. A live demonstration from Antares and Crest Solutions will help audience members absorb further knowledge on Serialization with the help of imported production equipment installed at the venue.

This latest event, will highlight evolving industry regulations for the implementation of industry Serialization, particularly the imminent deadlines for compliance with the DSCSA in the United States, as well as European Union requirements and those of emerging markets including China, South Korea, Brazil, and others. The discussions will enforce the need for all manufacturers, distributors and all supply chain partners to upgrade their production lines in compliance with traceability deadlines.

Industry professionals from pharmaceutical and biotech companies affected by global Serialization requirements will benefit from attending the PCI Serialization Forum.

For more information on the seminar, or to book your place, please click here:

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *

twenty + eighteen =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...